About Us

Guardant Health AMEA is a wholly owned subsidiary of Guardant Health, Inc., a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary tests, vast data sets and advanced analytics.


We are dedicated to helping patients at all stages of cancer live longer and healthier, through the power of blood tests and the data they unlock. Today our tests help inform treatment decisions for patients with advanced cancer. Our tests also detect residual and recurrent disease for patients with early-stage cancer and will soon screen to find cancer at its earliest and most treatable.

Clinical Samples Reported
Biopharma Partners
Ordering Oncologists
Peer-reviewed publications

Ordering Process

order icon

Physician to request a kit online or contact our local partner

blood donation icon

Blood/Tissue samples to be taken from the patient

email icon

Kit to be stored at room temperature and couriered to the laboratory

7 days icon

Test report to be emailed to physician

News & Events

World Lung Cancer Day
This World Lung Cancer Day, join us to raise support for those affected by one of the most common cancers in the world.…
GH AMEA leaders attended the World Economic Forum – Summer Davos Meeting of New Champions
Recently our GH AMEA leaders Simranjit Singh, CEO and Jasmeet (Jasmine) Kaur, Head of Government and Corporate Affairs attended the World Economic Forum…
Guardant Health Receives Regulatory Approval in Japan for Guardant360 CDx as Companion Diagnostic to ENHERTU
Guardant Health, Inc. has recently announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved the Guardant360® CDx liquid biopsy test…

Where to Find Us

Search Location


Distance Range Radius: KM


Get Your Directions

Show Distance In

Use my location to find the closest Service Provider near me

Number of Countries: 0


Message us